Correlation Between Viracta Therapeutics and OrganiGram Holdings

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Viracta Therapeutics and OrganiGram Holdings at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Viracta Therapeutics and OrganiGram Holdings into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Viracta Therapeutics and OrganiGram Holdings, you can compare the effects of market volatilities on Viracta Therapeutics and OrganiGram Holdings and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Viracta Therapeutics with a short position of OrganiGram Holdings. Check out your portfolio center. Please also check ongoing floating volatility patterns of Viracta Therapeutics and OrganiGram Holdings.

Diversification Opportunities for Viracta Therapeutics and OrganiGram Holdings

0.85
  Correlation Coefficient

Very poor diversification

The 3 months correlation between Viracta and OrganiGram is 0.85. Overlapping area represents the amount of risk that can be diversified away by holding Viracta Therapeutics and OrganiGram Holdings in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on OrganiGram Holdings and Viracta Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Viracta Therapeutics are associated (or correlated) with OrganiGram Holdings. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of OrganiGram Holdings has no effect on the direction of Viracta Therapeutics i.e., Viracta Therapeutics and OrganiGram Holdings go up and down completely randomly.

Pair Corralation between Viracta Therapeutics and OrganiGram Holdings

Given the investment horizon of 90 days Viracta Therapeutics is expected to under-perform the OrganiGram Holdings. In addition to that, Viracta Therapeutics is 1.38 times more volatile than OrganiGram Holdings. It trades about -0.44 of its total potential returns per unit of risk. OrganiGram Holdings is currently generating about -0.25 per unit of volatility. If you would invest  183.00  in OrganiGram Holdings on August 24, 2024 and sell it today you would lose (32.00) from holding OrganiGram Holdings or give up 17.49% of portfolio value over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
StrengthStrong
Accuracy100.0%
ValuesDaily Returns

Viracta Therapeutics  vs.  OrganiGram Holdings

 Performance 
       Timeline  
Viracta Therapeutics 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Viracta Therapeutics has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of weak performance in the last few months, the Stock's basic indicators remain fairly strong which may send shares a bit higher in December 2024. The current disturbance may also be a sign of long term up-swing for the company investors.
OrganiGram Holdings 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days OrganiGram Holdings has generated negative risk-adjusted returns adding no value to investors with long positions. Despite unfluctuating performance in the last few months, the Stock's technical and fundamental indicators remain fairly strong which may send shares a bit higher in December 2024. The recent confusion may also be a sign of long-lasting up-swing for the firm traders.

Viracta Therapeutics and OrganiGram Holdings Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Viracta Therapeutics and OrganiGram Holdings

The main advantage of trading using opposite Viracta Therapeutics and OrganiGram Holdings positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Viracta Therapeutics position performs unexpectedly, OrganiGram Holdings can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in OrganiGram Holdings will offset losses from the drop in OrganiGram Holdings' long position.
The idea behind Viracta Therapeutics and OrganiGram Holdings pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Bond Analysis module to evaluate and analyze corporate bonds as a potential investment for your portfolios..

Other Complementary Tools

Balance Of Power
Check stock momentum by analyzing Balance Of Power indicator and other technical ratios
Global Markets Map
Get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes
Content Syndication
Quickly integrate customizable finance content to your own investment portal
Fundamentals Comparison
Compare fundamentals across multiple equities to find investing opportunities
USA ETFs
Find actively traded Exchange Traded Funds (ETF) in USA